Prism MarketView

February 28, 2024 at 10:33 am

PRISM Rare Disease Spotlight: Capricor Therapeutics Advances Treatment for Duchenne Muscular Dystrophy

Rare disease company, Capricor Therapeutics (Nasdaq: CAPR), has been granted an in-person Type-B meeting with the FDA to discuss chemistry, manufacturing and controls (CMC) plans… [Read More]

February 27, 2024 at 2:05 pm

PRISM Rare Disease Spotlight: Voyager Therapeutics Selects Development Candidate for Friedreich’s Ataxia, Triggers $5M Milestone Payment

Voyager Therapeutics (Nasdaq: VYGR) has selected a lead development candidate in its Friedreich’s Ataxia (FA) program. The company expects the program to advance into first-in-human… [Read More]

February 27, 2024 at 2:02 pm

Viking Invades GLP-1 Space with Positive Topline Results; Shares Soar over 100%

Shares in clinical-stage biopharmaceutical company Viking Therapeutics, Inc. (Nasdaq: VKTX) have surged more than 100% in intraday trading on Tuesday after the company announced it… [Read More]

February 27, 2024 at 8:49 am

Tarsus Achieves Positive Topline Results in Lyme Disease Trial

Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) has announced positive topline results from a Phase 2a trial evaluating TP-05 (lotilaner), a novel, investigational oral therapeutic for the… [Read More]

February 21, 2024 at 8:43 am

Vaxxinity Advances Cholesterol Vaccine

A vaccine that could lower LDL cholesterol levels in the blood could soon be a reality for the nearly 94 million adults over the age… [Read More]

February 13, 2024 at 8:49 am

FDA Fast Track for BioXcel’s Prostate Cancer Treatment

Biopharmaceutical company, BioXcel Therapeutics, Inc. (Nasdaq: BTAI), has been granted FDA Fast Track designation for BXCL701 in combination with a CPI for the treatment of… [Read More]

February 12, 2024 at 12:15 pm

FDA Clearance for T2 Biosystems Diagnostic Panel

T2 Biosystems, Inc. (Nasdaq: TTOO) has received 510(k) clearance from the FDA for its expanded T2Bacteria® Panel, adding the capability to detect another bacterial species,… [Read More]

February 06, 2024 at 10:20 am

Alto Neuroscience Soars following Upsized IPO

Precision medicine company, Alto Neuroscience (NYSE: ANRO), began its first day of trading on Thursday last week with a mixed response from the market. Alto… [Read More]

January 30, 2024 at 2:38 pm

Vertex Pharmaceuticals Offers Hope with Non-Addictive Acute Pain Management

Vertex Pharmaceuticals (Nasdaq: VRTX) is offering hope to the 80 million Americans suffering with acute pain each year with a non-addictive pain management alternative. Today,… [Read More]

January 17, 2024 at 1:02 pm

Incannex Receives IRB Approval for Novel Cannabinoid Sleep Apnea Treatment Trial

Australian pharmaceutical company, Incannex Healthcare Inc. (Nasdaq: IXHL), has received independent Institutional Review Board (IRB) approval for a Phase 2/3 clinical trial to assess the… [Read More]

January 10, 2024 at 12:12 pm

Clearmind Medicine Meets with FDA to Discuss Clinical Trial in Alcohol Use Disorder; Shares Up 72%

Clearmind Medicine (Nasdaq: CMND) has completed a Type A meeting with the FDA to discuss the Company’s clinical trial of CMND-100 for the treatment of… [Read More]

January 10, 2024 at 9:07 am

Hyperfine Launches AI-powered Brain Imaging Software

Medical device company, Hyperfine, Inc. (Nasdaq: HYPR) has announced the launch of the eighth generation of its AI-powered Swoop® system software. The latest software has… [Read More]

Tag: BioTech